Impact of the Reduced Folate Carrier on the Accumulation of Active Thiamin Metabolites in Murine Leukemia Cells*

@article{Zhao2001ImpactOT,
  title={Impact of the Reduced Folate Carrier on the Accumulation of Active Thiamin Metabolites in Murine Leukemia Cells*},
  author={Rongbao Zhao and Feng Gao and Yanhua Wang and George A Diaz and Bruce D. Gelb and I. David Goldman},
  journal={The Journal of Biological Chemistry},
  year={2001},
  volume={276},
  pages={1114 - 1118}
}
  • R. Zhao, Feng Gao, +3 authors I. Goldman
  • Published 12 January 2001
  • Biology, Medicine
  • The Journal of Biological Chemistry
The thiamin transporter encoded bySLC19A2 and the reduced folate carrier (RFC1) share 40% homology at the protein level, but the thiamin transporter does not mediate transport of folates. By using murine leukemia cell lines that express no, normal, or high levels of RFC1, we demonstrate that RFC1 does not mediate thiamin influx. However, high level RFC1 expression substantially reduced accumulation of the active thiamin coenzyme, thiamin pyrophosphate (TPP). This decreased level of TPP… Expand
Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells.
TLDR
The data suggest that RFC1 may be one of the alternative transport routes available for TMP in some tissues when THTR-1 is mutated in the autosomal recessive disorder thiamine-responsive megaloblastic anemia. Expand
Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells*
TLDR
It is established for the first time that MRP1 is the primary folate efflux route in CEM leukemia cells and that the loss of folates and folic acid efflux activity is an efficient means of markedly augmenting cellular folate pools. Expand
Augmentation of Reduced Folate Carrier-Mediated Folate/Antifolate Transport through an Antiport Mechanism with 5-Aminoimidazole-4-Carboxamide Riboside Monophosphate
TLDR
The data indicate that intracellular ZMP trans-stimulates folate influx and inhibits folate efflux, which, together, produce a marked augmentation in the net cellular folate level. Expand
Other mechanisms to explain the role of reduced folate carrier in cancer
TLDR
High levels of RFC are essential for a correct uptake of methotrexate but also for efflux of intracellular thiamine and maybe for the transport of other anticancer agents. Expand
Biological Role, Properties, and Therapeutic Applications of the Reduced Folate Carrier (RFC-SLC19A1) and the Proton-Coupled Folate Transporter (PCFT-SLC46A1)
The mechanisms by which folates are transported across cell membranes have been an area of research interest for nearly five decades. Major transport systems include the facilitative carriers, theExpand
Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
TLDR
Evidence suggests that homo-oligomerization of RFC and PCFT monomeric proteins may be important for intracellular trafficking and/or transport function. Expand
SLC19A3 encodes a second thiamine transporter ThTr2.
TLDR
The function of SLC19A3, another member of this transporter family most recently cloned, is described after transient transfection of the cDNA into HeLa cells and it is indicated that this carrier has a high degree of specificity for vitamin B1. Expand
The Mechanism of Carrier-Mediated Transport of Folates in BeWo Cells: The Involvement of Heme Carrier Protein 1 in Placental Folate Transport
TLDR
It is concluded that pH-dependent folate uptake in BeWo cells is mediated by at least two carriers, including RFC and HCP1, both of which transport folates in the model cell line for the placenta. Expand
The Major Facilitative Folate Transporters Solute Carrier 19A1 and Solute Carrier 46A1: Biology and Role in Antifolate Chemotherapy of Cancer
TLDR
The molecular bases for methotrexate resistance associated with loss of RFC transport and for hereditary folate mal absorption, attributable to mutant PCFT, were determined and future studies should continue to translate molecular insights from basic studies of RFC and PCFT biology into new therapeutic strategies for cancer and other diseases. Expand
Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.
TLDR
This article focuses on the biology of the membrane transport system termed the "reduced folate carrier" or RFC with a particular emphasis on RFC structure and function. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Impact of Overexpression of the Reduced Folate Carrier (RFC1), an Anion Exchanger, on Concentrative Transport in Murine L1210 Leukemia Cells*
TLDR
Increased expression of RFC1, alone, may not be an efficient adaptive response to folate deprivation, and other factors may come into play to account for the marked increases in concentrative folate transport which occur when cells are subjected to low folate-selective pressure. Expand
A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells.
TLDR
The isolation and expression of a cDNA clone that restores RFC activity to human breast cancer cells defective in this transporter is described and the increase in methotrexate uptake observed in pRFC1-transfected MTXR ZR-75-1 cells reverses their resistance to this antitumor agent. Expand
Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
TLDR
Resistance to one antifolate, in this case MTX, because of a loss of RFC1 transport activity need not exclude the subsequent utility of another antIFolate that uses the same carrier. Expand
A Reduced Folate Carrier Mutation Produces Substrate-dependent Alterations in Carrier Mobility in Murine Leukemia Cells and Methotrexate Resistance with Conservation of Growth in 5-Formyltetrahydrofolate*
TLDR
The mutated RFC1 cDNA represents the first reported RFC1 mutation that confers resistance to MTX due to a markedly impaired influx with relative conservation of reduced folate transport, allowing tumor cells to meet their folate requirement with 5-CH3THF, the predominant blood folate. Expand
Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line (*)
TLDR
The MTXA line has both the mutant and the parental reduced folate carrier alleles but that expression appears to be restricted to the mutant allele, demonstrating that the methotrexate transport phenotype and resultant drug resistance in this cell line result from genetic/regulatory events at both alleles. Expand
Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line.
TLDR
In two partial revertants with increased MTX sensitivity isolated from the second-step resistant lines, MTX influx was increased but surface membrane-binding sites were unchanged suggesting that recovery of transport was due to normalization of carrier function rather than an increase in the number of carriers. Expand
Cloning of the Human Thiamine Transporter, a Member of the Folate Transporter Family*
TLDR
A cDNA from human placenta is isolated, which, when expressed heterologously in mammalian cells, mediates the transport of the water-soluble vitamin thiamine and is most likely the gene defective in the metabolic disorder,Thiamine-responsive megaloblastic anemia. Expand
Thiamine homeostasis in neuroblastoma cells
TLDR
The results suggest that cells of neuronal origin possess mechanisms regulating the intracellular concentration of thiamine, and suggest a binding or sequestration in intrACEllular compartments. Expand
Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis.
TLDR
Data suggest that several transmembrane domains, rather than the amino- and carboxyl-termini, and the large intracellular loop between the sixth and seventh transmemBRane domains play key roles as sites for RFC1 inactivation because of single point mutations. Expand
Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.
TLDR
It is proposed that the primary abnormality in TRMA is absence of a high-affinity thiamine transporter and that low intracellularThiamine concentrations in the mutant cells cause biochemical abnormalities that lead to apoptotic cell death. Expand
...
1
2
3
4
...